CIENCIASMEDICASNEWS: Medical News | Medical Articles: Role of Microglia in Multiple Sclerosis

miércoles, 5 de junio de 2019

Medical News | Medical Articles: Role of Microglia in Multiple Sclerosis

	June 5, 2019
	Multiple Sclerosis
	The latest multiple sclerosis news from News Medical

Role of Microglia in Multiple Sclerosis

Glial cells play many critical roles in the mediation of immune responses, transmission of axon potentials and maintenance of CNS (central nervous system) homeostasis. Demyelination refers to the loss of the myelin sheath, which affects the ability of the neurons to signal appropriately.

Read Full Article Here

			Innovative compound offers a new therapeutic approach to treat multiple sclerosis Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis.

			Daily cup of cocoa may reduce tiredness in multiple sclerosis A new study has shown that drinking a cup of flavonoid-enriched cocoa each day could help to reduce fatigue in people suffering from multiple sclerosis.

			Scientific breakthrough provides new hope for people living with multiple sclerosis A scientific breakthrough provides new hope for millions of people living with multiple sclerosis. Researchers at Oregon Health & Science University have developed a compound that stimulates repair of the protective sheath that covers nerve cells in the brain and spinal cord.

	High levels of blood lipids may worsen multiple sclerosis symptoms in obese patients A newly published paper in the Lancet journal EBioMedicine identifies a link between high levels of blood lipids and worsening of disease in multiple sclerosis patients who are overweight or obese.

	National Multiple Sclerosis Society awards grant for pilot study of social interaction in individuals with MS Ekaterina Dobryakova, PhD, and Pei-Pei Liu, PhD, were awarded a $50,000 grant from the National Multiple Sclerosis Society to conduct a novel study of outcome processing in individuals with MS.

	Study identifies protein regulator that induces Th17 cells to cause multiple sclerosis Inflammatory and autoimmune diseases such as psoriasis, rheumatoid arthritis, and multiple sclerosis (MS) are a major healthcare burden worldwide and are life-altering conditions for afflicted patients.

	FDA approves new oral drug to treat relapsing forms of multiple sclerosis The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.